Wholesalers Ask 2nd Circ. To Toss Shire Pay-For-Delay Win

Law360, New York (March 17, 2014, 3:13 PM EDT) -- Attorneys for drug wholesalers claiming Shire LLC smothered generic competition for attention-deficit-hyperactivity drug Adderall XR told a Second Circuit panel Monday that a district court wrongly concluded that Shire's alleged breaches of patent licensing agreements aren't actionable under federal antitrust law.

The wholesalers’ attorney Joseph Opper of Garwin Gerstein & Fisher LLP asked a three-judge panel in Manhattan to expand its legal precedent surrounding Section 2 of the Sherman Act to allow nonparties to a pay-for-delay deal between brand and generic drug manufacturers to obtain antitrust damages...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.